Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Changxing Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University | UNKNOWN |
| Suichang Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University | UNKNOWN |
| Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University |
Not provided
Not provided
Not provided
Not provided
Gallstone is a common disease in China.At present, the prevalence of gallstones in China is 15 %, and about 210 million people are sick. Acute cholecystitis is acute gallbladder inflammation, is one of the main complications of cholelithiasis or gallstones. The removal of gallbladder and gallstones in patients with acute cholecystitis in the presence of biliary pain will prevent the recurrence of gallbladder and reduce the risk of cholecystitis progression. If gallbladder perforation is not treated in time, the mortality rate is 30 %. Acute acalculous cholecystitis without treatment will be life-threatening, with a mortality rate of up to 50 %. At present, the vast majority of patients with acute cholecystitis are treated with 4-hole traditional laparoscopic cholecystectomy and open cholecystectomy. Their postoperative quality of life, pain and scar-related complications, remain major factors for patients.In recent years, with the renewal of the concept of minimally invasive surgery and the continuous advancement of instruments and technology, single-incision laparoscopic cholecystectomy has also maximized the quality of life after surgery and reduced postoperative pain and scar-related complications. At present, there are few reports on randomized controlled clinical trials of SILC in patients with acute cholecystitis, and there is a lack of large sample size studies.Due to the difficulty of SILC operation, the longer learning curve, the different equipment conditions and technical characteristics of each center, and the lack of standardized training, there is no effective consensus on the application indications and operation procedures of SILC in acute cholecystitis surgery. Based on the current status, the purpose of this study was to investigate the effect of SILC on postoperative quality of life, postoperative pain, scar assessment and postoperative complications in patients with acute cholecystitis, so as to propose a standardized single incision laparoscopic operation procedure in the treatment of acute cholecystitis.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Single-incision laparoscopic cholecystectomy | Experimental | SILC was defined as laparoscopic surgery done through a single trans-umbilical incision |
|
| Conventional laparoscopic cholecystectomy | Active Comparator | CLC was defined as three or four port surgery carried out with either French or American position. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Open cholecystectomy | Procedure | The experimental group and the control group were changed to open cholecystectomy when the operation was difficult to complete. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Quality of life (time to return to normal life) | The quality of life of patients after operation was investigated by a unified SF-36 questionnaire. The higher the final score, the better the quality of life. | 3 years |
| Measure | Description | Time Frame |
|---|---|---|
| Cosmetic result | Evaluation of postoperative incisional scarring using the Vancouver Scar Scale. The lower the score, the higher the scar satisfaction. | 3 years |
| Measure | Description | Time Frame |
|---|---|---|
| Grade II or above incidence of complications | Postoperative complications were defined by the clavien-dindo classification system. | 3 years |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Liu Daren, MD, PhD | Contact | +86-15968179036 | darenliu@zju.edu.cn | |
| Zha Liufan, MD, PhD | Contact | +86-18969952245 | liufanZha@outlook.com |
| Name | Affiliation | Role |
|---|---|---|
| Liu Daren, MD, PhD | Chief Physician | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Shexian Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University | Recruiting | Huangshan City | Anhui | China |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| UNKNOWN |
| Shexian Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
| 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China | Recruiting | Hangzhou | Zhejiang | No.88 Jiefang Road | China |
|
| Changxing Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University | Recruiting | Huzhou | Zhejiang | China |
|
| Suichang Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University | Recruiting | Lishui | Zhejiang | China |
|
| Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University | Recruiting | Meicheng | Zhejiang | China |
|